| |
| |
|
| Insider
Information: |
Bowden Christopher |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
59,654 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$539,270 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
59,654 |
|
|
| Total
Value |
$539,270 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Medical Officer |
2021-06-18 |
15,487 |
2015-06-01 |
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2022-06-22 |
44,167 |
2021-03-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2015-06-01 |
4 |
AS |
$120.67 |
$603,350 |
D/D |
(5,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2015-06-01 |
4 |
OE |
$35.16 |
$175,800 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2017-09-11 |
4 |
AS |
$65.00 |
$390,000 |
D/D |
(6,000) |
881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2017-09-11 |
4 |
OE |
$35.16 |
$210,960 |
D/D |
6,000 |
6,881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-02-01 |
4 |
OE |
$35.16 |
$70,320 |
D/D |
2,000 |
2,881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-02-01 |
4 |
AS |
$78.50 |
$157,500 |
D/D |
(2,000) |
881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-02-16 |
4 |
AS |
$77.51 |
$155,305 |
D/D |
(2,000) |
881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-02-16 |
4 |
OE |
$35.16 |
$70,320 |
D/D |
2,000 |
2,881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-03-14 |
4 |
AS |
$82.23 |
$164,661 |
D/D |
(2,000) |
881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-03-14 |
4 |
OE |
$35.16 |
$70,320 |
D/D |
2,000 |
2,881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-04-12 |
4 |
OE |
$35.16 |
$70,320 |
D/D |
2,000 |
2,881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-04-12 |
4 |
AS |
$84.78 |
$170,190 |
D/D |
(2,000) |
881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-05-08 |
4 |
AS |
$81.38 |
$162,760 |
D/D |
(2,000) |
881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-05-08 |
4 |
OE |
$35.16 |
$70,320 |
D/D |
2,000 |
2,881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-05-11 |
4 |
AS |
$84.81 |
$170,003 |
D/D |
(2,000) |
881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-05-11 |
4 |
OE |
$35.16 |
$70,320 |
D/D |
2,000 |
2,881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-06-12 |
4 |
AS |
$92.84 |
$185,786 |
D/D |
(2,000) |
881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-06-12 |
4 |
OE |
$35.16 |
$70,320 |
D/D |
2,000 |
2,881 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-07-10 |
4 |
AS |
$86.42 |
$173,512 |
D/D |
(2,000) |
924 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-07-10 |
4 |
OE |
$35.16 |
$70,320 |
D/D |
2,000 |
2,924 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-08-29 |
4 |
OE |
$35.16 |
$10,548 |
D/D |
300 |
1,224 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-08-29 |
4 |
AS |
$80.00 |
$24,000 |
D/D |
(300) |
924 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-08-30 |
4 |
AS |
$80.03 |
$136,051 |
D/D |
(1,700) |
924 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2018-08-30 |
4 |
OE |
$35.16 |
$59,772 |
D/D |
1,700 |
2,624 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2019-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,265 |
7,189 |
0 |
- |
|
70 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
